Reprieve Cardiovascular Raises $61M to Fund Pivotal Heart Failure Trial

What You Should Know: – Reprieve Cardiovascular, a clinical-stage company secures $61M in Series B funding led by Deerfield Management and included participation from several other investors, such as Arboretum Ventures, Lightstone Ventures, and an undisclosed strategic investor. – The funding round, which combines equity investment with a debt facility will be used to support ... Read More